Erlanger Health

Chattanooga, Tennessee 37403

2 studies enrolling now · 5 studies all time

What they study most

COPD, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Heart Failure, Heart Failure NYHA Class II, Heart Failure NYHA Class III, Non-muscle Invasive Bladder Cancer, Osteoarthritis, Ovarian Cancer, Post-traumatic Arthritis, Primary Peritoneal Carcinoma, Rheumatoid Arthritis

Studies at this site

• Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer — Recruiting now
• Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure — Enrolling by invitation
• A Global Clinical Study Investigating the Safety and Effectiveness of Smith and Nephew's Porous Knee System in Patients Who Need a Total Knee Replacement Due to Degenerative Arthritis, Post-traumatic Arthritis or Inflammatory Arthritis — Running, not enrolling
• A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer — Running, not enrolling
• Impairments That Affect Correct Inhaler Use in COPD — Running, not enrolling